Forbion is a leading European venture capital firm specializing in life sciences, supporting companies from research and development to commercialization. With a focus on high-impact investments, Forbion manages 5 billion across multiple funds, targeting areas such as autoimmune, cardiovascular, CNS, oncology, and rare diseases. The firm also explores biotech applications in food, agriculture, and environmental technologies.
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →